Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivation

PLoS ONE

Volumn 2, Issue 12, 2007, Pages

  Bourvis, Nadège ^a,b   Boelle, Pierre Yves ^a,b,c   Cesbron, Jean Yves ^d,e,f   Valleron, Alain Jacques ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIV GRENOBLE ALPES   (France)

^e CNRS   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CREUTZFELDT JAKOB DISEASE; DENTAL PRACTICE; DISEASE TRANSMISSION; ENDODONTICS; HUMAN; IATROGENIC DISEASE; INFECTION RISK; PRION; PRION DISEASE; RISK ASSESSMENT; SECONDARY INFECTION; TOOTH PULP; DRUG ANTAGONISM; EUROPE; THEORETICAL MODEL; UNCERTAINTY;

ANIMALIA;

CREUTZFELDT-JAKOB SYNDROME; ENDODONTICS; EUROPE; HUMANS; MODELS, THEORETICAL; PRIONS; RISK ASSESSMENT; UNCERTAINTY;

EID: 44349192074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001330     Document Type: Article

References (38)

1. Creutzfeld HG (1920) Über eine eigenartige herdfòrmige Erkrankung des Zentralnervensystems. Zeitschrift für die gesamte Neurologic und Psychiatric 57: 1-18.
2. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925.
3. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz, T, et al, (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1: 478-479.
4. Brown P. Preece M, Brandel JP, Sato T, McShane L, et A. (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium, Neurology 55: 1075-1081.
5. The European and Allied Countries Collaborative Study Group of GJD (2007) EuroCJD report. Available at: http://www.eurocjd.ed.ac.uk/ results.htm. Accessed: 1st November 2007.
6. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, et al. (1999) Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study, Lancet 353: 693-697.
7. Lewis V, Boyd A, Masters C, Collins S (2002) Apparently sporadic CJD and covert health-care transmissions. Lancet Neurology 1: 470-471.
8. Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie-Laupretre N, et al. (2002) Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 59: 543-548.
9. Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349: 1812-1820.
10. Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M, et al. (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 348: 711-719.
11. Herzog C, Riviere J, Lescoutra-Etchegaray N, Charbonnier A, Leblanc V, et al. (2005) PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol 79: 14339-14345.
12. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, et al. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD, Lancet Neurol 5: 393-398.
13. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, et al. (2001) Transmission of scrapie by steel-surface-bound prions. Mol Med 7: 679-684.
14. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, et al. (2000) Species-barrier-independent prion replication in apparently resistant species. PNAS 97: 10248 10253.
15. Thackray AM, Klein MA, Aguzzi A, Bojdoso R (2002) Chronic Subclinical Priori Disease Induced by Low-Dose Inoculum. J Virol 76: 2510-2517.
16. Taylor DM (2000) Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 159: 10-17.
17. Fichet G, Comoy E, Duval C, Antloga K, Dehen C, et al, (2004) Novel methods for disinfection of prion-contaminated medical devices. Lancet 364: 521-526.
18. Sanchez-Juan P, Ward H, De Silva R, Knight R, Will R (2004) Ophtalmic surgery and Creutzfeldt-Jacob disease. Br J Ophtalmol 88: 446-449.
19. Ingrosso L, Pisani F, Pocchiari M (1999) Transmission ofthe 263K scrapie strain by the dental route. J Gen Virol 80 (Pt 11): 3043-3047.
20. Blanquet-Grossard F, Sazdovitch V, Jean A, Deslys JP, Dormont D, et al. (2000) Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob discase. J Dent Res 79: 700.
21. Smith A, Letters S, Lange A, Perrett D, McHugh S, et al. (2005) Residual protein levels on reprocessed dental instruments. J Hosp Infect 61: 237-241.
22. Assurance Maladie des Salaries-Departement dentaire (2003) Frequence des actes bucco-dentaires selon les libelles de la classification commune des actes medicaux. Available at: http://www.ameli.fr/dl/ enquete_accodentaire.pdf. Accessed: December 22, 2006.
23. Ingle JI (2002) Endodontics. London: Hamilton.
24. McLean AR, Bostock CJ (2000) Scrapie infections initiated at varying doses: an analysis of 117 titradon experiments. Philos Trans R Soc, Lond B Biol Sci 355: 1043-1050.
25. Department of Health Economics and Research Division (2003) Risk Assessment for vGJD and Dentistry. Available at: http://www.dh.gov.uk/ assetRoot/04/07/83/02/04078302.PDF. Accessed: November 21, 2006.
26. Department of Health (2007) Precautionary advice given to dentists on re-use of instruments. Available at: http://www.gnn.gov.uk/environment/ fullDetail.asp?ReleaseID=279256&NewsAreaID= 2&NavigatedFromDepartment=False. Accessed: November 1st, 2007.
27. Spongiform Encephalopathy Advisory Committee (SEAC) (2007) NINETY SEVENTH MEETING OF THE SPONGIFORM ENCEPHALOPATHY ADVISORY COMMITTEE. Available at: http://www.seac.gov.uk/summaries/seac97_summary.pdf. Accessed: September 1st, 2007.
28. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5: 240-243.
29. Yan ZX, Stitz L, Heeg P, Pfaff E, Roth K (2004) Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies, Infect Control Hosp Epidemiol 25: 280-283.
30. Huillard d'Aignaux J, Cositagliola D, Maccario J, Billette de Villemeur T, Brandel JP, et al. (1999) Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 53: 1197-1201.
31. Barash P, Cullen B, Stocking R (2006) Clinical Anesthesia. Philadelphia: Lippincott Williams & Wilkins.
32. Bravo A, Sheth S, Chopra S (2001) Liver biopsy. N Engl J Med 344: 495-500.
33. Cunnigham F, Loveno KJ, Bloom SL, Hauth JC, Gilstrap LC, et al. (2005) Williams Obstetrics. ew-York: McGraw-Hill.
34. Gurevich I, Dubin R, Cunha BA (1996) Dental instrument and device sterilization and disinfection practices. J Hosp Infect 32: 295-304.
35. CCLIN Sud-Ouest (2004) Auto-evaluation des pratiques de prevention du risque infectieux chez les chirurgiens-dentistes d'Aquitaine. Available at: www.cclinsudouest.com/rapactivso/bilan04site.pdf. Accessed: December 22, 2006.
36. Bagg J, Sweeney CP, Roy KM, Sharp T, Smith A (2001) Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J 191: 87-90.
37. The CJD Incident Panel (2005) Management of possible exposure to CJD through medical procedures. A framework document. Available at: http://www.hpa.org.uk/infections/topics_az/cjd/framewoik_Aug%202005.pdf. Accessed: November 21, 2006.
38. Department of Health Economics and Research Division (2001) Risk assessment for transmission of vGJD via surgical instruments: a modelling approach and numerical scenarios. Available at: http://www.dh.gov.uk/assetRoot/04/07/53/88/04075388.pdf. Accessed: November 21, 2006.